CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment, 21354-21355 [E8-8475]
Download as PDF
<![CDATA[
21354
Federal Register / Vol. 73, No. 77 / Monday, April 21, 2008 / Notices
clinical personnel: Eighteen interviews
from administrative personnel and
twenty-three interviews from clinical
personnel. The question set is the same
for both clinical and administrative
personnel. The estimated time per
response is 1.5 hours for a total of 61.5
burden hours.
Exhibit 2 shows the estimated
annualized cost burden for the
respondents’ time to provide the
requested data. The hourly rate of
$32.13 is a weighted average of the
administrative personnel hourly wage of
$19.68 and the clinical personnel hourly
wage of $41.88. The total cost burden is
$1,976.
EXHIBIT 1.—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Data collection
Number of
responses per
respondent
Hours per
response
Total burden
hours
In-person interviews .........................................................................................
41
1
1.5
61.5
Total ..........................................................................................................
41
na
na
61.5
EXHIBIT 2.—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Data collection
Total burden
hours
Average
hourly wage
rate*
Total cost
burden
In-person interviews .........................................................................................
41
61.5
$32.13
$1,976
Total ..........................................................................................................
41
na
na
1,976
* Based upon the actual site personnel wages. Clinical personnel averages are weighted by the number of physicians, nurses and medical assistants in the sample. Administrative personnel averages are weighted by the number of administrators, lab, IT and other support personnel.
Total average is weighted by relative number of administrative and clinical personnel being interviewed.
Estimated Annual Costs to the Federal
Government
The total cost to the Federal
Government for this project is $393,457
over a two-year period. The average
annual cost is $196,728. The following
is a breakdown of average annual costs:
Direct Costs
Personnel—$108,320
Consultancies—$24,400
Data support—$5,000
Travel—$2,575
Supplies—$100
IRB review—$125
Dated: April 11, 2008.
Carolyn M. Clancy,
Director.
[FR Doc. E8–8444 Filed 4–18–08; 8:45 am]
BILLING CODE 4160–90–M
Indirect Costs
Indirect costs (40%)—$56,208
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
rwilkins on PROD1PC63 with NOTICES
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
VerDate Aug<31>2005
16:59 Apr 18, 2008
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Jkt 214001
Centers for Disease Control and
Prevention (CDC)
CDC/HRSA Advisory Committee on
HIV and STD Prevention and Treatment
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC and HRSA,
announces the following meeting of the
aforementioned committee:
Times and Dates: 8 a.m.–5 p.m., May 20,
2008; 8 a.m.–12:30 p.m., May 21, 2008.
Place: JW Marriott Buckhead, 3300 Lenox
Road, Atlanta, Georgia 30326, Telephone
(404) 262–3344, Fax (404) 262–8689.
Status: Open to the public, limited only by
the space available. The meeting room will
accommodate approximately 100 people.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Purpose: This Committee is charged with
advising the Director, CDC and the
Administrator, HRSA, regarding activities
related to prevention and control of HIV/
AIDS and other STDs, the support of health
care services to persons living with HIV/
AIDS, and education of health professionals
and the public about HIV/AIDS and other
STDs.
Matters To Be Discussed: Agenda items
include issues pertaining to (1) Hepatitis C in
the United States: Prevention, Surveillance,
Treatment and Care Issues; (2) CDC Division
of Sexual Transmitted Diseases Prevention,
External Research Review Recommendations
and Plans for Response; (3) Elimination of
Health Disparities—CDC’s Heightened
National Response and CDC’s Response to
HIV/AIDS among African American Men
Having Sex with Men; and (4) CDC’s New
Integrated Partner Counseling and Referral
Services Guidelines.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Committee Management
Specialist, CDC, Strategic Business Unit,
1600 Clifton Road, NE., Mailstop E–07,
Atlanta, Georgia 30333. Telephone (404)
639–8317, Fax (404) 639–8910.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
E:\FR\FM\21APN1.SGM
21APN1
Federal Register / Vol. 73, No. 77 / Monday, April 21, 2008 / Notices
Dated: April 11, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8475 Filed 4–18–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Establishment
of a Community-Clinical Partnership
for Primary Prevention of Type-2
Diabetes in Persons at High Risk,
Potential Extramural Project (PEP)
2008–R–09
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
rwilkins on PROD1PC63 with NOTICES
Time and Date: 1 p.m.–2:30 p.m., May 20,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Establishment of a
Community-Clinical Partnership for Primary
Prevention of Type-2 Diabetes in Persons at
High Risk, PEP 2008–R–09.’’
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8478 Filed 4–18–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Centers for Disease Control and
Prevention
Time and Date: 1 p.m.–2 p.m., May 14,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Preparing People with
Arthritis to Safely Select and Self Direct their
Physical Activity, PEP 2008–R–16.’’
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Evaluation of
Environmental and Policy
Interventions To Increase Fruit and
Vegetable Intake, Potential Extramural
Project (PEP) 2008–R–11
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 1 p.m.–3 p.m., May 29,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Evaluation of Environmental
and Policy Interventions to Increase Fruit
and Vegetable Intake, PEP 2008–R–11.’’
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8480 Filed 4–18–08; 8:45 am]
BILLING CODE 4163–18–P
16:59 Apr 18, 2008
Jkt 214001
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8483 Filed 4–18–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0189] (formerly
Docket No. 2003N–0312)
Meeting to Present Changes to the
Animal Feed Safety System Project
and the Ranking of Feed Hazards
According to the Risks They Pose to
Animal and Public Health; Part 3:
Swine Feed Example; Public Meeting
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Preparing
People With Arthritis To Safely Select
and Self Direct Their Physical Activity,
Potential Extramural Project (PEP)
2008–R–16
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
VerDate Aug<31>2005
21355
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
following public meeting: ‘‘Meeting to
Present Changes to the Animal Feed
Safety System (AFSS) Project and the
Ranking of Feed Hazards According to
the Risks They Pose to Animal and
Public Health; Part 3: Swine Feed
Example.’’ We are holding the public
meeting in an effort to gather further
information from you, our stakeholders,
on changes to AFSS that will help
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 73, Number 77 (Monday, April 21, 2008)]
[Notices]
[Pages 21354-21355]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8475]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
CDC/HRSA Advisory Committee on HIV and STD Prevention and
Treatment
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), CDC and HRSA, announces the following
meeting of the aforementioned committee:
Times and Dates: 8 a.m.-5 p.m., May 20, 2008; 8 a.m.-12:30 p.m.,
May 21, 2008.
Place: JW Marriott Buckhead, 3300 Lenox Road, Atlanta, Georgia
30326, Telephone (404) 262-3344, Fax (404) 262-8689.
Status: Open to the public, limited only by the space available.
The meeting room will accommodate approximately 100 people.
Purpose: This Committee is charged with advising the Director,
CDC and the Administrator, HRSA, regarding activities related to
prevention and control of HIV/AIDS and other STDs, the support of
health care services to persons living with HIV/AIDS, and education
of health professionals and the public about HIV/AIDS and other
STDs.
Matters To Be Discussed: Agenda items include issues pertaining
to (1) Hepatitis C in the United States: Prevention, Surveillance,
Treatment and Care Issues; (2) CDC Division of Sexual Transmitted
Diseases Prevention, External Research Review Recommendations and
Plans for Response; (3) Elimination of Health Disparities--CDC's
Heightened National Response and CDC's Response to HIV/AIDS among
African American Men Having Sex with Men; and (4) CDC's New
Integrated Partner Counseling and Referral Services Guidelines.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh,
Committee Management Specialist, CDC, Strategic Business Unit, 1600
Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333. Telephone
(404) 639-8317, Fax (404) 639-8910.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
[[Page 21355]]
Dated: April 11, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-8475 Filed 4-18-08; 8:45 am]
BILLING CODE 4163-18-P
